Trading Summary - January 15. More satisfactory progress

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
222
Trading Summary - January 15.

More satisfactory progress for $EVSV today even though all top traders were busy with other movers from my Watch List which had news - notably $SKDI.

Again we had the artificially low walked down ask at .3400 taken out with 2 buys for a total of 3,416 shares.

The next ask up was .4100.

Initially, the basher / scammers on iHub were too busy posting nonsense to even notice the move. Only after it was pointed one of them walk down a further token 2,500 at .3400.

Again the point has been made that 50K > 100K in buys would get .7000+ up.

There was a new bidder in depth at .2900.

There were no paint down attempts (apart from the walked down ask).

Expect ask hits ahead when we get the updates on the 3 meetings held on January 13, on monetization of the first hemp crop, and the shareholder update PR which is known to be coming soon per the Tweet yesterday from the CEO.

Overall, 3,416 shares were bought today - similar to yesterday..

As was proven again on January 9:

- $EVSV remains extremely thin to the upside.

- Anyone who doesn't yet have 50K > 150K - the amount the top traders have - will have to hit the ask to get them and only one is likely to be able to buy 100K under .7000.

- Attempts by iHub scammers to dupe people to trade on the bid are not going to succeed.

- When walked down asks are taken out, the longs in $EVSV know how to prevent the manipulators getting back in again.

The main whales traders of $EVSV already have their 100K > 150K inventory and are happy to accumulate on the bid from daily paint downs until such time as they choose to run it up - or jump on and buy at the same time as a company buyback or large buy by partners - as happened on December 17, 2019.

Remember, every 10,000 shares bought below .5000 is worth a $5K profit at $1 - $7.5K profit at $1.50 - and $10K profit at $2.00 for the savvy and patient.

Items below the line unchanged since the last long-version Trading Summary:

Top traders of $EVSV have now each earned close to $6-figures on it in the last 3 years and multiple $5-figures in 2019 - most of which is since the successful r/s 12 months ago - due to multiple surges and the thin share structure for a stock in this price range.

The latest DD / Rolling Brief is here:

https://investorshangout.com/post/view?id=5640847

Key Points from recent PRs (not including December 17 PR) are here:

https://investorshangout.com/post/view?id=5619497

The Share Structure was last updated on December 31, 2019 - showing no change to the Unrestricted O/S.

The 2019 Q3 was filed on November 18, 2019 in a timely manner.

The 2019 Q2 was filed on August 7, 2019 in a timely manner and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

Trading on December 17 illustrated yet again just how difficult it is to accumulate an inventory of 100K > 150K of $EVSV - like the top traders in it have - to be ready for the move to $1 + - within even a .2000 price band increment.

The next buyer of 100K at a time should see .6000 or .7000 up - and the next 200K might see $1+.

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

The usual moving around of the insignificant undercut asks by the iHub scammers of course has no effect and they are currently being allowed to continue to post to themselves on iHub completely oblivious to the fact that all traders of significance are networking by other means on telegram and slack.

The modus operandi of the iHub scammers hasn't changed for 12 months since they failed to buy at .0001 on the day before the successful r/s: post blatant nonsense on iHub + attempt to support their fake narrative by trading at or below the visible bid price (often with orders placed before the open + then not pay attention to actual other trading that follows + attempt to walk a small ask down to artificially low levels + not realize that their manipulation attempts don't affect the views of the 172 social media OTC influencers who have $EVSV on their radar now.

All these manipulation attempts enable top traders on low commission rates - who don't have to worry about partial fills - to just keep accumulating cheap shares almost daily.

As I have warned before, the scammers who attempt paint downs on thin stocks are likely to find themselves detected by their brokers compliance department and reported to the SEC. This is what will then happen:

https://www.sec.gov/news/press-release/2019-216

I'll be mainly #boycottiHub - I have now alerted the more influential / serious Penny Stock Geeks and relevant Whale Team rooms on telegram and slack.

In addition of course we have 181 traders / analysts / alerters on social media that have $EVSV on their radar to start scaling in and / or jumping on board "just-in-time".

Warning ! Anyone who is seen posting nonsense on iHub on any on the thinly traded stocks I'm a shareholder in - especially when small paint downs are also seen along with undercut asks - can expect to have their user ID passed to the SEC which has now started to take action against those using the exact modus operandi I have detected and commented on for the past 2 years:

https://www.sec.gov/news/press-release/2019-216




Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading